ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2026
The MINT Sprint 2.0: a Picture Naming Test for Detection of Naming Impairments in ΜCI Due or Not to AD, Greek Version.
Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveNaming impairments are among the earliest cognitive deficits in Alzheimer's disease (ad), particularly affecting semantic memory and lexical retrieval. This study evaluated the diagnostic utility of the Greek adaptation of the MINT Sprint 2.0, a culturally tailored picture-naming test, in identifying naming deficits in preclinical and early ad.
methodA total of 170 Greek-speaking participants were classified into three diagnostic groups: (1) MCI biomarker positive (preclinical ad), (2) MCI biomarker negative, and (3) cognitively intact (CI) (biomarker negative). Participants completed the MINT Sprint 2.0, comprising naming accuracy (MINTFIRSTPASS) and response latency (MINTFIRSTPASSTIME). Multivariate and univariate ANOVAs were used to assess group differences.
resultsDiagnosis significantly influenced performance across both measures, accounting for 26.5% of variance in accuracy and 52.7% in latency (p < .01). MANOVA revealed a large multivariate effect (Pillai's Trace V = 0.674, p < .01). Post hoc tests confirmed that all groups differed significantly on both variables, with biomarker-positive individuals performing worse and slower than other groups. MINT Sprint 2.0 elicited significantly different performance across diagnostic groups, supporting its potential utility in detecting early AD-related changes and offering enhanced sensitivity to early lexical retrieval deficits and response speed. Strong correlations between MINT Sprint and 15-BNT scores supported convergent validity.
conclusionThe Greek MINT Sprint 2.0 is a valid and sensitive tool for detecting early ad-related naming impairments. Its cultural relevance and inclusion of response time make it superior to traditional naming tests, offering potential as a primary screening measure in Greek-speaking populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.